A Promising Start! ∣ SBK Included in Growth Catalog and Selected as “Chengdu IPO Reserve Enterprise”

In a bid to support high-quality enterprises in securing IPO financing and drive Chengdu’s economic development, the Chengdu Local Financial Regulation Bureau, along with other relevant departments, has initiated the process of creating the “Chengdu IPO Reserve Enterprise Resource Pool”. The resource pool is divided into three tiers based on the IPO readiness of the companies: Foundation Catalog, Growth Catalog, and Key Catalog. After a rigorous evaluation process, Chengdu Shibeikang has successfully been included in the “Chengdu IPO Reserve Enterprise Resource Pool”.

A total of 66 companies from the Chengdu High-Tech Industrial Development Zone were included in this latest round of the “Chengdu IPO Reserve Enterprise Growth Catalog”. As part of this initiative, the Chengdu Local Financial Regulation Bureau will provide these companies with standardized guidance to accelerate their IPO processes, and help them address any challenges faced during their preparation to expedite their listing.

SBK is a high-tech company specializing in pharmaceutical research, development, and sales. We have built a comprehensive innovation platform focused on drug metabolism differentiation, with more than 10 R&D pipelines spanning short-, mid-, and long-term projects. Several of these are nearing or have already entered the production application stage.

Looking ahead, the company will work closely with authorities at all levels, leverage the support from capital markets to drive comprehensive upgrades in management and operations, and contribute to Chengdu’s high-quality economic growth.